Christopher G. Larsen

Christopher G. Larsen

Auto-generated profile, based on publicly available information

Christopher G. Larsen

Department of Orthopaedic Surgery, Northwell Health, New Hyde Park, NY

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2019 in The Journal of Arthroplasty
Verified
Journal Article
Closed access
KSKevin A. Sonn
Kevin A. Sonn
CLChristopher G. Larsen
Christopher G. Larsen
WAWilliam Adams
William Adams
NBNicholas M. Brown
Nicholas M. Brown
CMCraig J. McAsey
Craig J. McAsey

1 September 2021 in JBJS Reviews
Verified
Journal Article
Closed access
CLChristopher G. Larsen
Christopher G. Larsen
MFMichael J. Fitzgerald
Michael J. Fitzgerald
KNKate W. Nellans
Kate W. Nellans
LLLewis B. Lane
Lewis B. Lane
» Most cases of de Quervain tenosynovitis can be managed with nonoperative measures, and the mainstay of treatment is corticosteroid injection (CSI). The use of ultrasound may improve the accuracy of injections and can help to identify and localize injections to separate subcompartments. » For patients who are in the third trimester of pregnancy or breastfeeding, there is no contraindication to CSI as studies have shown that it can provide optimal symptomatic relief to the mother without impacting the baby. » When nonoperative treatment is unsuccessful, surgical release of the first dorsal compartment (FDC) can provide excellent symptom relief. Open release performed through a longitudinal incision allows for better visualization of the underlying anatomy, resulting in fewer injuries to underlying structures and a lower incidence of hypertrophic scarring compared with a transverse incision. » For surgeons who are comfortable performing endoscopic techniques, endoscopic FDC release can result in quicker symptom improvement, superior scar cosmesis, and a lower incidence of radial sensory nerve injury. » Studies have shown that FDC release can safely and effectively be performed using the WALANT (wide-awake local anesthesia no tourniquet) technique, which has the potential for cost savings without compromising quality or patient comfort.

2 August 2021 in HAND
Verified
Journal Article
Closed access
PDF file
MFMichael J. Fitzgerald
Michael J. Fitzgerald
TMTaylor Mustapich
Taylor Mustapich
HLHaixiang Liang
Haixiang Liang
CLChristopher G. Larsen
Christopher G. Larsen
KNKate W. Nellans
Kate W. Nellans
DGDaniel A. Grande
Daniel A. Grande
Background: As hand surgeons, tendon injuries and lacerations are a particularly difficult problem to treat, as poor healing potential and adhesions hamper optimal recovery. Adipose-derived stem cells (ADSCs) have been shown to aid in rat Achilles tendon healing after a puncture defect, and this model can be used to study tendon healing in the upper extremity. We hypothesized that ADSCs cultured with growth differentiation factor 5 (GDF5) and platelet-derived growth factor (PDGF) would improve tendon healing after a transection injury. Methods: Rat Achilles tendons were transected and then left either unrepaired or repaired. Both groups were treated with a hydrogel alone, a hydrogel with ADSCs, or a hydrogel with ADSCs that were cultured with GDF5 and PDGF prior to implantation. Tissue harvested from the tendons was evaluated for gene expression of several genes known to play an important role in successful tendon healing. Histological examination of the tendon healing was also performed. Results: In both repaired and unrepaired tendons, those treated with ADSCs cultured with GDF5/PDGF prior to implantation showed the best tendon fiber organization, the smallest gaps, and the most organized blood vessels. Treatment with GDF5/PDGF increased expression of the protenogenesis gene SOX9, promoted cell-to-cell connections, improved cellular proliferation, and enhanced tissue remodeling. Conclusions: Adipose-derived stem cells cultured with GDF5/PDGF prior to implantation can promote tendon repair by improving cellular proliferation, tenogenesis, and vascular infiltration. This effect results in a greater degree of organized tendon healing.

1 April 2020 in JBJS Reviews
Verified
Journal Article
Open access
CLChristopher G. Larsen
Christopher G. Larsen
ESErik J. Stapleton
Erik J. Stapleton
JSJonathan Sgaglione
Jonathan Sgaglione
MSMatthew Sgaglione
Matthew Sgaglione
TGTodd Goldstein
Todd Goldstein
DGDaniel A. Grande
Daniel A. Grande
» Three-dimensional (3D)-printing technology has evolved dramatically in the last 30 years, from large machines with poor resolution to those with micron-level capabilities that sit on a desktop. This technology is being utilized in numerous medical applications, particularly in orthopaedic surgery. » Over the past decade, technological advances have allowed for the application of this technology to the field of tissue engineering through the process of 3D bioprinting. » Of interest to orthopaedic surgeons, active areas of research utilizing this technology involve the bioprinting of articular cartilage, bone, menisci, and intervertebral discs.

1 June 2021 in Surgery
Verified
Journal Article
Closed access
CLChristopher G. Larsen
Christopher G. Larsen
CBChristine D. Bub
Christine D. Bub
BSBenjamin C. Schaffler
Benjamin C. Schaffler
TWTimothy Walden
Timothy Walden
JIJessica M. Intravia
Jessica M. Intravia

1 November 2020 in Journal of Orthopaedics
Verified
Journal Article
Closed access
CLChristopher G. Larsen
Christopher G. Larsen
WCWilliam K. Crockatt
William K. Crockatt
MFMichael Fitzgerald
Michael Fitzgerald
NMNanette Matos
Nanette Matos
HGHoward J. Goodman
Howard J. Goodman
Shachar KenanShachar Kenan
Shachar Kenan